No Data
No Data
Axsome Therapeutics Is Maintained at Buy by Mizuho
Axsome Therapeutics Is Maintained at Buy by Mizuho
Mizuho Securities Ups Price Target on Axsome Therapeutics to $109 From $108, Keeps Buy Rating
Axsome Therapeutics (AXSM) has an average rating of buy and price targets ranging from $90 to $190, according to analysts polled by Capital IQ. Price: 79.98, Change: +0.81, Percent Change: +1.02
Analysts Offer Insights on Healthcare Companies: Regulus (RGLS), Axsome Therapeutics (AXSM) and Olink Holding (OLK)
Optimistic Buy Rating for Axsome Therapeutics: Diverse Portfolio and Market Potential Despite Challenges
Citigroup Adjusts Price Target on Axsome Therapeutics to $127 From $125, Maintains Buy Rating
Axsome Therapeutics (AXSM) has an average buy rating and a price target range of $90 to $190, according to analysts polled by Capital IQ. Price: 77.77, Change: +0.42, Percent Change: +0.54
Tesla To $120? Here Are 10 Top Analyst Forecasts For Tuesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Keybanc bo
No Data
Salmon Klein : are you in $Macrogenics (MGNX.US)$ ? tell me when good to jump in
MangoXXXX Salmon Klein: Now
Stonkedtrader003 Salmon Klein: Do your own research , I think hovering in bottom and buy signal from pattern about to begin , do not follow me blindly my
Salmon Klein Stonkedtrader003: I am waiting to reach 14.8 or so, but I am busy working, if it reached the bottom and you are in...any good feedback is always very welcomed bro...just that so thanks
Stonkedtrader003 Salmon Klein: Double higher bottom in intra-day might not hit below 14ish or if so still chance for 2 more trading sideways days, I am almost 25% down ( reason holding beyond top) anyway